Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Raizada, Devesh
- Exploring the Modulatory Effect of Albumin on Calcium Phosphate Crystallization
Abstract Views :185 |
PDF Views:65
Authors
Priyadarshini
1,
Devesh Raizada
1,
Pragya Kumar
1,
Tanya Singh
1,
Trisha Pruthi
1,
Abhishek Negi
1,
Lokesh Nigam
2,
Naidu Subbarao
2
Affiliations
1 Department of Biotechnology, Jaypee Institute of Information Technology, Noida 201 307, IN
2 School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi 110 067, IN
1 Department of Biotechnology, Jaypee Institute of Information Technology, Noida 201 307, IN
2 School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi 110 067, IN
Source
Current Science, Vol 117, No 6 (2019), Pagination: 1083-1089Abstract
Urolithiasis, also known as renal lithiasis, is a commonly occurring disease in humans. Calculi are formed in the urinary tract, including the tubular region of the kidney. Calcium phosphate crystals, especially hydroxyapatite, are responsible for nidus formation in the more commonly occurring calcium oxalate kidney stones. In the present study, effect of different concentrations of human serum albumin on nucleation, growth and demineralization of calcium phosphate crystallization using growth assay system and its confirmation with in silico study have been analysed. Human serum albumin shows inhibitory effect on nucleation, while it shows both stimulatory as well as inhibitory activity on the growth of calcium phosphate crystals. The results suggest that albumin plays a role in both inhibition as well as promotion of calcium phosphate crystallization. The in silico study indicates involvement of Tyr-161, Arg-222 and Lys- 195 and Lys-199 residues of albumin with calcium phosphate crystal.Keywords
Albumin, Calcium Phosphate, Crystallization, Nucleation, Urolithiasis.Full Text
References
- López, M. and Hoppe, B., History, epidemiology and regional diversities of urolithiasis. Pediatr. Nephrol., 2010, 25(1), 49–59.
- Coe, F. L., Parks, J. H. and Asplin, J. R., The pathogenesis and treatment of kidney stones. N. Engl. J. Med., 1992, 327(16), 1141– 1152.
- Yuvarani, T., Manjula, K. and Gopu, P., Growth characterization of calcium, hydrogen phosphate dihydrate crystals influenced by Costus igneus aqueous extract. Int. J. Pharm. Pharm. Sci., 2017, 9(5), 173–178.
- Aduayi, O. S. and Famurewa, O. C., Cystolithiasis with coexisting nephrolithiasis: a radiodiagnostic discovery in an adult Nigerian male with lower urinary tract symptoms. J. Med. Invest. Pract., 2015, 10, 30–32.
- Siener, R. and Hesse, A., The effect of a vegetarian and different omnivorous diet on urinary risk factors for uric acid stone formation. Eur. J. Nutr., 2003, 42(6), 332–337.
- Evan, A. P. et al., Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat. Rec., 2007, 290, 1315–1323.
- Kaneko, K., Kobayashi, R., Yasuda, M., Izumi, Y., Yamanobe, T. and Shimizu, T., Comparison of matrix proteins in different types of urinary stone by proteomic analysis using liquid chromatography-tandem mass spectrometry. Int. J. Urol., 2012, 19, 765–772.
- Jaggi, M., Nakagawa, Y., Zipperle, L. and Hess, B., Tamm– Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol. Res., 2007, 35(2), 55–62.
- Devuyst, O., Dahan, K. and Prison, Y., Tamm–Horsfall protein or uromodulin: new ideas about an old molecule. Nephrol. Dial. Transplant, 2015, 20, 1290–1294.
- Terkeltaub, R., Santoro, D., Mandel, G. and Mandel, N., Serum and plasma inhibit neutrophil stimulation by hydroxyapatite crystals, evidence that serum α2-HS glycoprotein is a potent and specific crystal-bound inhibitor. Arthritis Rheum., 1988, 31, 1081– 1089.
- Atmani, F. and Khan, S., Modulators of urinary stone formation. Urol. Int., 2002, 68, 54–59.
- Dussol, B. et al., Analysis of the soluble organic matrix of five morphologically different kidney stones. Urol. Res., 1995, 23, 45– 51.
- Quinlan, G. J., Martin, G. S. and Evans, T. W., Albumin: biochemical properties and therapeutic potential. Hepatology, 2005, 41, 1211–1219.
- Hankins, J., The role of albumin in fluid and electrolyte balance. J. Infus. Nurs., 2006, 29, 261–265.
- Sitar, M. E., Aydin, S. and Cakatay, U., Human serum albumin and its relation with oxidative stress. Clin. Lab., 2013, 59, 945– 952.
- Cerini, C. et al., Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Kidney Int., 1999, 55, 1776–1786.
- Liu, J., Jiang, H. and Liu, X., How does bovine serum albumin prevent the formation of kidney stone? A kinetics study. J. Phys. Chem. B., 2006, 110, 9085–9089.
- Kabra, S. G., Kabra, V., Banerji, P., Jain, L. K., Bhargava, A. and Chaturvedi, R. P., Inhibitors of in vitro mineralization from flexor tendons of rabbits and their role in biological mineralization. Indian J. Exp. Biol., 1978, 16, 212–217.
- Natelson, S. and Penniall, R., Colorimetric estimation of ultramicro quantities of calcium in human serum as complex with alizarin. Anal. Chem., 1955, 27, 434–437.
- Gomori, G., A modification of the colorimetric phosphorus determination for use with the photoelectric colorimeter. J. Lab. Clin. Med., 1942, 27, 955–960.
- Williams, J. C. Jr, Zarse, C. A., Jackson, M. E., Witzmann, F. A. and McAteer, J. A., Variability of protein content in calcium oxalate monohydrate stones. J. Endourol., 2006, 20(8), 560– 564.
- Lowry, O. H., Rosbrough, N. J., Farr, A. L. and Randall, R. J., Protein measurement with the Folin Phenol reagent. J. Biol. Chem., 1951, 193, 265–275.
- Bamane, R., Chitre, T. and Rakholiya, V. K., Molecular docking studies of quinoline-3-carbohydrazide as novel PTP1B inhibitors as potential antihyperglycemic agents. Der Pharma Chem., 2011, 3, 227–237.
- Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A. and Klicic Glide, J. J., A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem., 2004, 47, 1739–1749.
- Balaji, B. and Ramanathan, M., Prediction of estrogen receptor β ligands potency and selectivity by docking and MM-GBSA scoring methods using three different scaffolds. J. Enzyme Inhib. Med. Chem., 2012, 27, 832–844.
- Brennan, S. and Carrell, S., α1-Antitrypsin Christchurch, 363 Glu → Lys: mutation at the P′5 position does not affect inhibitory activity. Biochim. Biophys. Acta, 1986, 873, 13–19.
- Nishizawa, K., Nishizawa, M., Gnanasambandam, R., Sachs, F., Sukharev, S. I. and Suchyna, T. M., Effects of Lys to Glu mutations in GsMTx4 on membrane binding, peptide orientation, and self-association propensity, as analyzed by molecular dynamics simulations. Biochim. Biophys. Acta, 2015, 1848, 2767– 2778.
- Shinbrot, E. et al., Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res., 2014, 24, 1740– 1750.
- Cherepanov, D. et al., Reduction and protonation of the secondary quinone acceptor of Rhodobactersphaeroides photosynthetic reaction center: kinetic model based on a comparison of wild-type chromatophores with mutants carrying Arg → Ile substitution at sites 207 and 217 in the L-subunit. Biochim. Biophys. Acta, 2000, 1459, 10–34.
- Ishtikhar, M., Ali, M. S., Atta, M., Nigam, L., Subbarao, N. and Khan, R. H., Temperature dependent rapid annealing effect induces amorphous aggregation of human serum albumin. J. Lumin., 2015, 167, 399–407.
- Stamatelou, K. K., Francis, M. E., Jones, C. A., Nyberg, L. M. and Curhan, G. C., Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int., 2003, 63, 1817–1823.
- Sourcie, J. M., Thun, M. J., Coates, R. J., McClellan, W. and Austin, H., Demographic and geographic variability of kidney stones in the United States. Kidney Int., 1994, 46, 893–899.
- Alelign, T. and Petros, B., Kidney stone disease: an update on current concepts. Adv. Urol., 2018, 2018, 3068365.